ETHYL-1-BENZOYLAMINO-2-TRITYLSULFANYLCYCLOPROPANE-CARBOXYLATE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | B7B8PIdoGU5 |
|---|---|
| InChI | InChI=1S/C32H29NO3S/c1-2-36-30(35)31(33-29(34)24-15-7-3-8-16-24)23-28(31)37-32(25-17-9-4-10-18-25,26-19-11-5-12-20-26)27-21-13-6-14-22-27/h3-22,28H,2,23H2,1H3,(H,33,34)/t28-,31+/m0/s1 |
| InChIKey | UYFRSNDJMYALCU-QCENPCRXSA-N |
| Mol Weight | 507.6 g/mol |
| Molecular Formula | C32H29NO3S |
| Exact Mass | 507.186815 g/mol |
| Enantiomer InChIKey | UYFRSNDJMYALCU-MVSFAKPFSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
BOC-PHE-CYS((O)ME)-CYS(TRT)-OME
(+/-)-METHYL-N-BENZOYL-ALPHA-(E)-[2'-FLUORO-2'-(TRI-N-BUTYL)-STANNYL]-VINYLPHENYLALANINATE
3-Benzamido-3-phenyl-5(E)-(bromomethylidene)tetrahydro-2-furanone
(+/-)-METHYL-N(ALPHA)-N(EPSILON)-DIBENZOYL-ALPHA-(E)-[2'-FLUORO-2'-(TRI-N-BUTYL)-STANNYL]-VINYLLYSINATE
CHBA-(NO2)NLE-PHE-VAL-OME
2-(4-fluorophenyl)-2-oxoethyl 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-(methylsulfonyl)butanoate
2-(4-chlorophenyl)-2-oxoethyl 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-(methylsulfonyl)butanoate
3,3,3-Trifluoro-2-(4-fluoro-benzoylamino)-2-(5-methyl-[1,3,4]thiadiazol-2-ylamino)-propionic acid ethyl ester
1H-isoindole-2-acetic acid, 2,3-dihydro-1,3-dioxo-alpha-(phenylmethyl)-, 2-(4-chlorophenyl)-2-oxoethyl ester
1-BENZAMIDO-2-(m-HYDROXYPHENYL)CYCLOPROPANECARBOXYLIC ACID, HYDRAZIDE
| Title | Journal or Book | Year |
|---|---|---|
| A Novel Class of Conformationally Constrained, Masked Cysteines: Synthesis of 2-Alkyl- and 2-Arylsulfanyl-1-aminocyclopropanecarboxylic Acids | The Journal of Organic Chemistry | 1999 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.